Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-048811)

Filing Details

Accession Number:: 0001209191-22-048811
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-06 17:24:30
Reporting Period:: 2022-09-06

Accepted Time:: 2022-09-06 17:24:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850261	Sorrento Therapeutics Inc.	SRNE	Biological Products, (No Disgnostic Substances) (2836)	330344842

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1470981	Henry Ji	C/O Sorrento Therapeutics, Inc. 4955 Directors Place San Diego CA 92121	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-09-06	55,555	$1.96	4,676,917	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,271,693	Indirect	See Footnote
Common Stock	40,000	Indirect	By spouse

Footnotes

Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.